Search in:

European Clinical Respiratory Journal Volume 3, 2016 - Issue 1

Submit an article Journal homepage

Open access

870

Views

CrossRef citations to date

Altmetric

Original Research Articles

NT-proBNP <95 ng/l can exclude pulmonary hypertension on echocardiography at diagnostic workup in patients with interstitial lung disease

Charlotte AndersenDepartment of Clinical Pharmacology, Aarhus University Hospital, Aarhus, DenmarkCorrespondence[email protected]

Søren MellemkjærDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark

Ole HilbergDepartment of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark

Elisabeth BendstrupDepartment of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark

Article: 32027 | Received 22 Apr 2016, Accepted 07 Jul 2016, Published online: 28 Jul 2016

Cite this article
https://doi.org/10.3402/ecrj.v3.32027
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (13)

Karen Kristina Nyvold Johnson, Tobias Stemann Lau, Simon Mark Dahl Baunwall, Gerda Elisabeth Villadsen, Vibeke Guldbrand Rasmussen, Henning Grønbæk, Riina Karoliina Oksjoki & Gitte Dam. (2023) The role of N‐terminal pro‐brain natriuretic peptide, chromogranin A, and 5‐hydroxyindoleacetic acid in screening for carcinoid heart disease. Journal of Neuroendocrinology 35:10.
Crossref

Roseanne K. Chan, Mark Horrigan, Nicole S. L. Goh & Yet H. Khor. (2022) Clinical assessment for pulmonary hypertension in interstitial lung disease. Internal Medicine Journal 53:8, pages 1415-1422.
Crossref

Raj Parikh, David M. O'Sullivan & Harrison W. Farber. (2023) The PH‐ILD Detection tool: External validation and use in patients with ILD. Pulmonary Circulation 13:3.
Crossref

Bodrug Nicolae & Luca Ecaterina. (2022) Natriuretic peptides in elderly patients with chronic obstructive pulmonary disease. The Egyptian Journal of Bronchology 16:1.
Crossref

Steven D. Nathan, Peter Fernandes, Mitchell Psotka, Patrizio Vitulo, Lucilla Piccari, Katerina Antoniou, Sylvia M. Nikkho & Norman Stockbridge. (2022) Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension. Pulmonary Circulation 12:4.
Crossref

Raj Parikh, Ippokratis Konstantinidis, David M. O'Sullivan & Harrison W. Farber. (2022) Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection. Pulmonary Circulation 12:4.
Crossref

Farbod N. Rahaghi & Franck F. Rahaghi. (2021) PH-ILD: Identification, Evaluation, and Monitoring: A Diagnostic View From Both Sides. Advances in Pulmonary Hypertension 20:4, pages 103-108.
Crossref

Małgorzata Sobiecka, Katarzyna Lewandowska, Jarosław Kober, Monika Franczuk, Agnieszka Skoczylas, Witold Tomkowski, Jan Kuś & Monika Szturmowicz. (2020) Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?. Lung 198:3, pages 547-554.
Crossref

Johan van Cleemput, Andrea Sonaglioni, Wim A. Wuyts, Monica Bengus, John L. Stauffer & Sergio Harari. (2018) Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management. Advances in Therapy 36:2, pages 298-317.
Crossref

J. Nowak, B. Hudzik, J. Niedziela, P. Rozentryt, M. Zembala & M. Gąsior. (2018) Role of Pro-Brain Natriuretic Peptide Serum Concentration in the Detection of Pulmonary Hypertension in Patients With End-Stage Lung Diseases Referred for Lung Transplantation. Transplantation Proceedings 50:7, pages 2044-2047.
Crossref

Sabina A. Guler, Kina Ellison, Mohmmed Algamdi, Harold R. Collard & Christopher J. Ryerson. (2018) Heterogeneity in Unclassifiable Interstitial Lung Disease. A Systematic Review and Meta-Analysis. Annals of the American Thoracic Society 15:7, pages 854-863.
Crossref

Simon Bax, Athol Wells, Laura Price & John Wort. 2017. Pulmonary Hypertension and Interstitial Lung Disease. Pulmonary Hypertension and Interstitial Lung Disease 103 128 .

G. A. Margaritopoulos, K. M. Antoniou, C. P. Denton & A. U. Wells. (2016) Reply. Arthritis & Rheumatology 69:1, pages 240-241.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

NT-proBNP <95 ng/l can exclude pulmonary hypertension on echocardiography at diagnostic workup in patients with interstitial lung disease

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

NT-proBNP <95 ng/l can exclude pulmonary hypertension on echocardiography at diagnostic workup in patients with interstitial lung disease

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date